「no」の検索結果
164件：51～55件目を表示
-
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
milies, in order to ensure the transparency of clinical trials. This information on this website is not intended to advertise or promote SENJU ’s products, or to recruit participants. Participants in ...
http://www.senju.co.jp/english/rd/trial.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, ...
http://www.senju.co.jp/english/rd/society/ -
学会发表 | 研究与开发 | 千寿制药株式会社
2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, ...
https://www.senju.co.jp/chinese/rd/society/ -
Management Policy | About Senju | SENJU Pharmaceutical
iewpoints is the starting point for all our business activities. "If I were you"We should not do to others what we would not like to be done to us.We should do to others what would make us h...
http://www.senju.co.jp/english/about/philosophy.html -
Milestones in Our History | About Senju | SENJU Pharmaceutical
1947 Apri Hiroshi Tsuzuki (CEO) established the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 Feb...
https://www.senju.co.jp/english/about/history.html